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Abstract 
    To clarify the direct effects of androgens, the changes in the hypothalamic levels of 
reproductive and appetite regulatory factors induced by chronic dihydrotestosterone 
(DHT) administration were evaluated in female rats. DHT treatment increased the BW 
and food intake of the ovariectomized rats, but not the estradiol (E2)-treated rats. DHT 
administration suppressed the expression of a hypothalamic anorexigenic factor. 
Although the kisspeptin (Kiss1) mRNA levels of the anterior hypothalamic block (the 
anteroventral periventricular nucleus, AVPV) were increased in the E2-treated rats, DHT 
administration did not affect the Kiss1 mRNA levels of the AVPV in the ovariectomized 
or E2-treated rats. Conversely, DHT administration reduced the Kiss1 mRNA levels of 
the posterior hypothalamic block (the arcuate nucleus, ARC) in the ovariectomized rats. 
Although the Kiss1 mRNA levels of the posterior hypothalamic block (ARC) were 
decreased in the E2-treated rats, DHT administration did not affect the Kiss1 mRNA 
levels of the ARC in these rats. Serum luteinizing hormone levels of these groups 
exhibited similar patterns to the Kiss1 mRNA levels of the ARC. These results showed 
that DHT affects the production of hypothalamic reproductive and appetite regulatory 
factors, and that these effects of DHT differ according to the estrogen milieu. 
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Introduction 
    Sex hormones influence reproductive function and body weight (BW) regulation in 
mammals and humans [1]. It has been well established that estrogen play pivotal roles in 
the regulation of gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) 
secretion via positive and negative feedback effects on hypothalamic kisspeptin and its 
receptor Kiss1r, which is a positive regulator of GnRH [2]. Estrogen also affects the 
activity of hypothalamic RFamide-related peptides/gonadotropin inhibitory hormone 
(RFRP/GnIH) and its receptor, G protein-coupled receptor (GPR)147, which is a negative 
regulator of GnRH and LH [3,4]. It has been also well established that estrogen play 
pivotal roles in the regulation of appetite and BW through the modulation of 
hypothalamic orexigenic and anorexigenic factors [5-9]. 
    In contrast to estrogen, the effects of androgens on reproductive function and BW 
regulation in females have not been fully established, although it has been reported that 
hyperandrogenemia is usually accompanied by visceral obesity and ovulatory disorders 
in humans [10]. Almost all of the basic studies that have investigated the effects of 
androgens on female physiological functions involved animal models of polycystic ovary 
syndrome (PCOS), which is a representative hyperandrogenism-related disorder [11]. 
Although the effects of androgens on reproductive and BW regulatory functions and the 
mechanisms underlying these effects have been partially clarified by the aforementioned 
studies [11], some other effects, particularly the effects of androgens on hypothalamic 
functions, have not been fully evaluated. Recently, we and other groups have investigated 
hypothalamic kisspeptin levels, as well as serum gonadotropin levels, in PCOS model 
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rodents; however, there were marked discrepancies between the results of these studies 
[12-14]. The protocols used to produce the PCOS model differed among the studies, and 
ovarian intact rodents were used; i.e., the rats were not only administered androgen, and 
androgen-induced changes in ovarian functions might affect hypothalamic functions, 
which could explain the discrepancies among the studies’ results. In addition, only a few 
studies have evaluated the effects of androgens on hypothalamic appetite regulatory 
factors in females [15], and there are no data about the effects of androgens on 
hypothalamic RFRP/GnIH in females. 
    To clarify the direct effects of androgens on reproductive and BW regulatory 
functions, we evaluated the effects of chronic dihydrotestosterone (DHT), which is a non-
aromatizing androgen, on hypothalamic factors under ovariectomized (OVX) and stable 
estradiol (E2) milieu conditions. 
 
Materials and Methods 
Animals 
    Wistar female rats were purchased from Charles River Laboratories Japan, Inc., 
(Kanagawa, Japan) and housed in a room under controlled light (12 h light, 12 h darkness; 
lights turned on at 0800 and turned off at 2000) and temperature (24°C) conditions. In 
total, 29 rats were used in this study. All animal experiments were conducted in 
accordance with the ethical standards of the institutional animal care and use committee 
of the University of Tokushima. All surgical procedures were carried out under sodium 
pentobarbital- (60-80 mg/kg, intraperitoneal, i.p.) or sevoflurane-induced anesthesia. 
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Effects of chronic DHT administration in ovariectomized (OVX) rats and OVX and 
estradiol-administered rats 
    At 15 weeks of age, the rats were randomly divided into the no treatment (control), 
DHT-administered (DHT), E2-administered (E2), and E2 and DHT-administered 
(E2+DHT) groups. All rats were OVX bilaterally and implanted with a silastic tube filled 
with crystalline steroid hormones under sodium pentobarbital-induced anesthesia. The 
parts of the tubes filled with DHT and E2 measured 30 mm and 3.0 mm in length, 
respectively [16,17]. In the control group, the rats were implanted with empty tubes. All 
of the tubes were removed and replaced with new ones 4 weeks later under sevoflurane-
induced anesthesia. The rats were individually housed after surgery, and their BW and 
food intake (FI) were checked every 7 days. At 8 weeks after the OVX and implantation 
procedures, the rats were sacrificed by decapitation under sevoflurane-induced anesthesia. 
The weights of visceral fat (parametrial, perirenal, and mesenteric deposits) and 
subcutaneous fat (inguinal deposits) were measured, and the brain and blood were 
collected. Serum was separated by centrifugation and stored at -20°C, and tissues were 
stored at -80°C. 
Hormone assays 
    Serum E2 levels were measured by a commercial laboratory (SRL, Tokyo, Japan) 
using an electrochemiluminescence immunoassay (ECLIA; Roche Diagnostics GmbH, 
Mannheim, Germany). Serum LH levels were measured using a radioimmunoassay (RIA) 
(rat LH [I-125] RIA kit, Institute of Isotopes Co., Ltd., Tokyo, Japan). 
Quantitative real-time polymerase chain reaction 
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    Whole hypothalamic explants were dissected from the frozen brains, as described 
previously [15]. Briefly, the target region of the brain was dissected out via an anterior 
coronal cut at the posterior border of the mammillary bodies, parasagittal cuts along the 
hypothalamic fissures, and a dorsal cut 2.5 mm from the ventral surface. Subsequently, 
the obtained brain tissue was divided into two blocks using coronal cuts at the posterior 
border of the optic chiasm. The anterior hypothalamic block contained the anteroventral 
periventricular nucleus (AVPV), and the posterior hypothalamic block contained the 
arcuate nucleus (ARC) [18]. Kisspeptin in the AVPV and ARC receives positive and 
negative feedback signals from estrogen, respectively [2]. Total RNA was isolated from 
the hypothalamic explants and visceral fat using a TRIzol® reagent kit (Invitrogen Co., 
Carlsbad, CA, USA) and an RNeasy® mini kit (Qiagen Gmbh, Hilden, Germany). cDNA 
was synthesized with oligo (deoxythymidine) primers at 50°C using the SuperScript III 
first-strand synthesis system for the real-time polymerase chain reaction (PCR; Invitrogen 
Co.). The PCR analysis was performed using the StepOnePlusTM real-time PCR system 
(PE Applied Biosystems, Foster City, CA, USA) and FAST SYBR® green. The mRNA 
levels of neuropeptide Y (NPY), proopiomelanocortin (POMC), prepro-orexin (pporexin), 
Kiss1 (the gene encoding kisspeptin), Kiss1r, RFRP/GnIH (the gene encoding the 
kisspeptin receptor), and GPR147 in the posterior hypothalamus, and the Kiss1 mRNA 
levels of the anterior hypothalamus were measured. The mRNA expression level of each 
molecule was normalized to that of GAPDH. Dissociation curve analysis was also 
performed for each gene at the end of the PCR. Each amplicon generated a single peak. 
The primer sequences, product sizes, and annealing temperatures are shown in Table 1. 
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The PCR conditions were as follows: initial denaturation and enzyme activation at 95°C 
for 20 s, followed by 45 cycles of denaturation at 95°C for 3 s, and annealing and 
extension for 30 s. 
Statistical analyses 
    All data are presented as the mean ± standard deviation (SD). The statistical analyses 
were conducted using one-way or two-way analysis of variance (ANOVA) together with 
the Tukey-Kramer post-hoc test for comparisons among the groups. 
 
Results 
    The E2-treated groups (E2, E2+DHT) exhibited significantly smaller BW changes 
than the non-E2-treated groups (control, DHT). The DHT group displayed greater BW 
changes than the control group, whereas the BW changes in the E2 group did not differ 
from those seen in the E2+DHT group (Figs. 1A and B). Similarly, the DHT group 
demonstrated greater cumulative FI compared with the control group, whereas the 
cumulative FI of the E2 group did not differ from that of the E2+DHT group (Figs. 1A 
and B). The weights of visceral fat, subcutaneous fat, total fat, and lean body mass 
recorded in the E2-treated groups (E2, E2+DHT) were significantly lighter than those 
observed in the non-E2-treated groups (control, DHT) (Figs. 2A-D). There were no 
significant differences in these parameters between the control and DHT groups or 
between the E2 and E2+DHT groups. The serum LH levels of the DHT, E2, and E2+DHT 
groups were significantly lower than that of the control group (Fig. 2E). The serum E2 
levels of the E2-treated groups were significantly higher than those of the non-E2-treated 
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groups. 
    There were no significant differences in the hypothalamic NPY or pporexin mRNA 
levels among the examined groups (Figs. 3A and B), whereas the hypothalamic POMC 
mRNA level of the E2+DHT group was significantly lower than that of the control group 
(Fig. 3C). In the anterior hypothalamus, the Kiss1 mRNA levels of the E2-treated groups 
(E2, E2+DHT) were significantly higher than those of the non-E2-treated groups (control, 
DHT) (Fig. 3D). However, there were no significant differences in the anterior 
hypothalamic Kiss1 mRNA level between the control and DHT groups or between the E2 
and E2+DHT groups. On the other hand, the posterior hypothalamic Kiss1 mRNA levels 
of the DHT, E2, and E2+DHT groups were significantly lower than that of the control 
group (Fig. 3E). The posterior hypothalamic Kiss1r mRNA level of the E2+DHT group 
was significantly lower than those of the other groups (Fig. 3F). The posterior 
hypothalamic RFRP and GPR147 mRNA levels of the E2+DHT group were lower than 
those of the control and DHT groups (Fig. 3H). 
 
Discussion 
    Sex hormones play roles in reproductive function and BW regulation in mammals 
and humans [1]. It has been well established that the effects of estrogen on GnRH/LH are 
mainly mediated by hypothalamic kisspeptin and RFRP/GnIH [2-4] and that its effects 
on appetite are mediated by hypothalamic orexigenic and anorexigenic factors [1,5-9]. In 
contrast to estrogen, the effects of androgens on reproductive function and BW regulation, 
especially on hypothalamic functions, in females have not been fully established. 
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Although some studies have examined the effects of androgens on hypothalamic 
reproductive functions, the results were disputed since ovarian intact PCOS animal 
models were used [12-14]. Thus, to clarify the direct effects of androgens on reproductive 
functions, we evaluated the changes in the hypothalamic levels of reproductive factors 
induced by chronic DHT administration under OVX and stable E2 milieu conditions. 
Kisspeptin has been detected in both the AVPV and ARC, and it was reported that lower 
levels of estrogen reduce kisspeptin activity in the ARC and suppress GnRH/LH secretion, 
whereas higher levels of estrogen increase kisspeptin activity in the AVPV and induce 
surges in GnRH/LH production [2]. Thus, we separated the hypothalamus into anterior 
(AVPV) and posterior (ARC) blocks and evaluated the Kiss1 mRNA levels of these 
blocks. As a result, we found that although the Kiss1 mRNA levels of the anterior 
hypothalamic block (AVPV) were significantly higher in the E2-treated groups (E2 and 
E2+DHT groups) than in the non- E2-treated groups (control and DHT groups), they did 
not differ between the groups that were and were not administered DHT in the OVX or 
E2-treated rats. These results indicate that in the AVPV the Kiss1 gene is sensitive to E2, 
but not DHT. On the other hand, the Kiss1 mRNA levels in the posterior hypothalamic 
block (ARC) were significantly lower in the E2-treated groups than in the non-E2-treated 
groups. In addition, the Kiss1 mRNA levels of the posterior hypothalamic block (ARC) 
were significantly lower in the group treated with DHT than in the group that was not 
administered DHT among the OVX rats, but not the E2-treated rats. These results indicate 
that in the ARC the Kiss1 gene is sensitive to both E2 and DHT. As the serum LH levels 
of these groups exhibited similar patterns to their Kiss1 mRNA levels in the ARC; i.e., 
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the levels of LH were decreased by both E2 and DHT, these steroids might have stronger 
effects on gonadotropin levels in the ARC than in the AVPV. Interestingly, although 
neither DHT nor E2 affected the hypothalamic mRNA levels of Kiss1r or RFRP/GnIH 
when administered alone, the co-administration of DHT and E2 suppressed the 
hypothalamic concentrations of these molecules. The administration of DHT reduced the 
hypothalamic mRNA levels of GPR147 in both the OVX and E2-treated rats. We could 
not evaluate the physiological roles of these alterations in this study; however, we 
speculate that these changes might represent a counter-regulatory mechanism that 
attenuates the effects of marked changes in kisspeptin activity. 
    In the present study, the BW gains observed in the OVX groups were significantly 
larger than those seen in the E2-treated groups. The BW gains and FI recorded in the 
group treated with DHT were significantly larger than those observed in the group that 
was not administered DHT in the OVX rats, whereas they did not differ in the E2-treated 
rats. On the other hand, the amounts of visceral and subcutaneous fat were not affected 
by DHT administration in either the OVX or E2-treated rats. These findings indicate that 
DHT itself does not affect the amount of body fat under OVX or stable E2 milieu 
conditions. It has been reported that both BW and fat weight were increased in DHT-
treated PCOS models [11,19,20] and that they were also increased in testosterone-treated 
female rats [15]. As mentioned above, because androgens were administered to ovarian 
intact female animals and estrous cyclicity was disturbed in almost all of these animals in 
the aforementioned studies, some of the observed effects of androgens on BW and body 
fat might have been induced by disturbances in ovarian function; i.e., estrogen deficiency 
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or irregularities in estrogen production. In this study, the hypothalamic mRNA levels of 
orexigenic factors; i.e., NPY and pporexin, were not changed by the administration of 
DHT in the OVX or E2-treated rats. On the other hand, the hypothalamic mRNA level of 
POMC, an anorexigenic factor, was reduced by the co-administration of DHT and E2. As 
it has been reported that kisspeptin acts as a positive regulator of POMC expression in 
the hypothalamus, reductions in Kiss1 and Kiss1r expression might be related to the 
alterations in the POMC level seen in the DHT+E2 group [21,22]. However, such changes 
might not be directly involved in the regulation of BW or FI. Thus, we could not detect 
any hypothalamic mechanisms by which DHT increases FI under OVX conditions. 
Further studies are needed to clarify the mechanisms by which androgens affect BW and 
FI regulation.   
    In summary, this study showed that DHT affects BW, FI, and the expression of 
hypothalamic reproductive and appetite regulatory factors and that these effects of DHT 
differ according to the estrogen milieu. In addition, the effects of DHT on Kiss1 mRNA 
levels in the anterior (AVPV) and posterior (ARC) hypothalamus were markedly different. 
DHT might have stronger effects on gonadotropin levels in the ARC than in the AVPV. 
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Figure legends 
Fig. 1 
Weekly body weight (BW) changes (% of initial BW) (A, B) and cumulative food intake 
(FI; g/initial BW) (C, D) observed in the control, dihydrotestosterone (DHT)-treated, 
estradiol (E2)-treated, and DHT+E2-treated rats 
 Data are expressed as mean ± SEM values. Different letters (a-c) indicate significant 
differences (P <0.05). 
 
Fig. 2 
Visceral, subcutaneous, and total fat weight (A-C); lean body mass (D); and serum LH 
and serum estradiol levels (E, F) in the control, dihydrotestosterone (DHT)-treated, 
estradiol (E2)-treated, and DHT+E2-treated rats 
 Data are expressed as mean ± SEM values. Different letters (a-c) indicate significant 
differences (P <0.05). 
 
Fig. 3 
The mRNA levels of hypothalamic orexigenic and anorexigenic factors (A-C) and 
hypothalamic reproductive factors (D-H) 
 The mRNA expression levels of the control rats are expressed as 1.0. Data are expressed 
as mean ± SEM values. Different letters (a-c) indicate significant differences (P <0.05). 
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Primer Sequence Product size (bp) Annealing T (℃)
Kiss1 forward ATG ATC TCG CTG GCT TCT TGG  91 65
Kiss1 reverse GGT TCA CCA CAG GTG CCA TTT T 
Kiss1r forward TGT GCA AAT TCG TCA ACT ACA TCC  193 65
Kiss1r reverse AGC ACC GGG GCG GAA ACA GCT GC 
RFRP forward GAG TCC TGG TCA AGA GCA AC  93 60
RFRP reverse ACT GGC TGG AGG TTT CCTA T 
GPR147 forward GTG TCT GCA TCG GTT TTC AC  92 60
GPR147 reverse TTC CGA AGG GTC AGC TTC 
OBRb forward GCAGCTATGGTCTCACTTCTTTTG 113 63
OBRb reverse GTTCCCTGGGTGCTCTGA
NPY forward GGG GCT GTG TGG ACT GAC CCT 148 66
NPY reverse GAT GTA GTG TCG CAG AGC GGA G
pporexin forward GCC GTC TCT ACG AAC TGT TG 303 60
pporexin reverse CGA GGA GAG GGG AAA GTT AG
POMC forward CCT CAC CAC GGA AAG CA 104 66
POMC reverse TCA AGG GCT GTT CAT CTC C
GAPDH forward ATG GCA CAG TCA AGG CTG AGA 64 70
GAPDH reverse CGC TCC TG GAA GAT GGT GAT
Table 1    Primer sequences, product sizes and annealing temperature. 
